Corvus Pharmaceuticals Inc (CRVS)
Sales/Maturities of Investments
$117.19M
TTM · Period ending: · USD
CRVS Sales/Maturities of Investments
Latest reported$117.19Mperiod ending
Latest reported$117.19Mperiod ending
CRVS TTM Sales/Maturities of Investments ($14.10M → $117.19M)
TTM Sales/Maturities of Investments
High-resolution chart · PNG
CRVS sales/maturities of investments history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Sales/Maturities of Investments (USD) |
|---|---|
| 117,193,000 | |
| 89,123,000 | |
| 84,128,000 | |
| 74,078,000 | |
| 60,493,000 | |
| 49,996,000 | |
| 42,630,000 | |
| 37,464,000 | |
| 41,879,000 | |
| 49,519,000 | |
| 62,623,000 | |
| 68,913,000 | |
| 70,327,000 | |
| 60,077,000 | |
| 43,162,000 | |
| 30,265,000 | |
| 13,115,000 | |
| 23,565,000 | |
| 30,922,000 | |
| 35,961,000 | |
| 48,081,000 | |
| 56,444,000 | |
| 87,385,000 | |
| 108,159,000 | |
| 132,264,000 | |
| 142,286,000 | |
| 141,866,000 | |
| 152,278,000 | |
| 166,248,000 | |
| 151,289,000 | |
| 132,024,000 | |
| 117,200,000 | |
| 112,080,000 | |
| 156,524,000 | |
| 173,401,000 | |
| 252,499,000 | |
| 223,799,000 | |
| 221,224,000 | |
| 217,924,000 | |
| 122,725,000 | |
| 109,025,000 | |
| 47,100,000 | |
| 14,100,000 | |
| 6,300,000 |